Akari Therapeutics Plc (AKTX) Net income 2016–2025
Akari Therapeutics Plc (AKTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.3MFY2025 · since FY2016: -$18.1M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +12.6% |
| FY2024 | -$19.8M | -97.8% |
| FY2023 | -$10.0M | +43.6% |
| FY2022 | -$17.7M | -1.9% |
| FY2021 | -$17.4M | -2.0% |
| FY2020 | -$17.1M | -1.4% |
| FY2019 | -$16.8M | +17.8% |
| FY2018 | -$20.5M | +42.1% |
| FY2017 | -$35.4M | -95.1% |
| FY2016 | -$18.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →